117 related articles for article (PubMed ID: 9767390)
21. Time-dependent expression of donor- and host-specific major histocompatibility complex class I and II antigens in allogeneic dopamine-rich macro- and micrografts: comparison of two different grafting protocols.
Brandis A; Kuder H; Knappe U; Jödicke A; Schönmayr R; Samii M; Walter GF; Nikkhah G
Acta Neuropathol; 1998 Jan; 95(1):85-97. PubMed ID: 9452826
[TBL] [Abstract][Full Text] [Related]
22. Allografts of CNS tissue possess a blood-brain barrier: III. Neuropathological, methodological, and immunological considerations.
Broadwell RD; Baker BJ; Ebert PS; Hickey WF
Microsc Res Tech; 1994 Apr; 27(6):471-94. PubMed ID: 8012052
[TBL] [Abstract][Full Text] [Related]
23. RNAi-mediated silencing of HLA A2 suppressed acute rejection against human fibroblast xenografts in the striatum of 6-OHDA lesioned rats.
Liang C; Xu Y; Zheng D; Sun X; Xu Q; Duan D
J Neuroimmunol; 2016 Aug; 297():28-37. PubMed ID: 27397073
[TBL] [Abstract][Full Text] [Related]
24. Quinolinate immunoreactivity in experimental rat brain tumors is present in macrophages but not in astrocytes.
Moffett JR; Els T; Espey MG; Walter SA; Streit WJ; Namboodiri MA
Exp Neurol; 1997 Apr; 144(2):287-301. PubMed ID: 9168830
[TBL] [Abstract][Full Text] [Related]
25. Human FGF-1 gene delivery protects against quinolinate-induced striatal and hippocampal injury in neonatal rats.
Hossain MA; Fielding KE; Trescher WH; Ho T; Wilson MA; Laterra J
Eur J Neurosci; 1998 Aug; 10(8):2490-9. PubMed ID: 9767380
[TBL] [Abstract][Full Text] [Related]
26. Acute and chronic changes in kynurenate formation following an intrastriatal quinolinate injection in rats.
Ceresoli-Borroni G; Guidetti P; Schwarcz R
J Neural Transm (Vienna); 1999; 106(3-4):229-42. PubMed ID: 10392532
[TBL] [Abstract][Full Text] [Related]
27. Comparison of mesencephalic free-floating tissue culture grafts and cell suspension grafts in the 6-hydroxydopamine-lesioned rat.
Meyer M; Widmer HR; Wagner B; Guzman R; Evtouchenko L; Seiler RW; Spenger C
Exp Brain Res; 1998 Apr; 119(3):345-55. PubMed ID: 9551835
[TBL] [Abstract][Full Text] [Related]
28. Neural progenitor implantation restores metabolic deficits in the brain following striatal quinolinic acid lesion.
Visnyei K; Tatsukawa KJ; Erickson RI; Simonian S; Oknaian N; Carmichael ST; Kornblum HI
Exp Neurol; 2006 Feb; 197(2):465-74. PubMed ID: 16310773
[TBL] [Abstract][Full Text] [Related]
29. Rat nigral xenografts survive in the brain of MHC class II-, but not class I-deficient mice.
Duan WM; Westerman MA; Wong G; Low WC
Neuroscience; 2002; 115(2):495-504. PubMed ID: 12421616
[TBL] [Abstract][Full Text] [Related]
30. Intracerebral xenografts of dopamine neurons: the role of immunosuppression and the blood-brain barrier.
Brundin P; Widner H; Nilsson OG; Strecker RE; Björklund A
Exp Brain Res; 1989; 75(1):195-207. PubMed ID: 2495977
[TBL] [Abstract][Full Text] [Related]
31. Reversal of behavioural abnormalities by fetal allografts in a novel rat model of striatonigral degeneration.
Wenning GK; Granata R; Laboyrie PM; Quinn NP; Jenner P; Marsden CD
Mov Disord; 1996 Sep; 11(5):522-32. PubMed ID: 8866493
[TBL] [Abstract][Full Text] [Related]
32. Intrathalamic striatal grafts survive and affect circling behaviour in adult rats with excitotoxically lesioned striatum.
Labandeira-Garcia JL; Liste I; Tobio JP; Rozas G; Lopez-Martin E; Guerra MJ
Neuroscience; 1995 Oct; 68(3):737-49. PubMed ID: 8577370
[TBL] [Abstract][Full Text] [Related]
33. Glial cell line-derived neurotrophic factor improves survival of ventral mesencephalic grafts to the 6-hydroxydopamine lesioned striatum.
Granholm AC; Mott JL; Bowenkamp K; Eken S; Henry S; Hoffer BJ; Lapchak PA; Palmer MR; van Horne C; Gerhardt GA
Exp Brain Res; 1997 Aug; 116(1):29-38. PubMed ID: 9305812
[TBL] [Abstract][Full Text] [Related]
34. Immunohistochemical visualization of newly formed quinolinate in the normal and excitotoxically lesioned rat striatum.
Lehrmann E; Molinari A; Speciale C; Schwarcz R
Exp Brain Res; 2001 Dec; 141(3):389-97. PubMed ID: 11715084
[TBL] [Abstract][Full Text] [Related]
35. Effects of macrophage migration inhibitory factor and macrophage migration stimulatory factor on function and survival of foetal dopaminergic grafts in the 6-hydroxydopamine rat model of Parkinson's disease.
Schwarz SC; Schwarz J; Sautter J; Oertel WH
Exp Brain Res; 1998 May; 120(1):95-103. PubMed ID: 9628407
[TBL] [Abstract][Full Text] [Related]
36. Neuroinflammation in the generation of post-transplantation dyskinesia in Parkinson's disease.
Lane EL; Soulet D; Vercammen L; Cenci MA; Brundin P
Neurobiol Dis; 2008 Nov; 32(2):220-8. PubMed ID: 18675359
[TBL] [Abstract][Full Text] [Related]
37. Angiogenic and neurotrophic effects of vascular endothelial growth factor (VEGF165): studies of grafted and cultured embryonic ventral mesencephalic cells.
Pitzer MR; Sortwell CE; Daley BF; McGuire SO; Marchionini D; Fleming M; Collier TJ
Exp Neurol; 2003 Aug; 182(2):435-45. PubMed ID: 12895454
[TBL] [Abstract][Full Text] [Related]
38. Reactive astrocytes of the quinolinic acid-lesioned rat striatum express GFRalpha1 as well as GDNF in vivo.
Bresjanac M; Antauer G
Exp Neurol; 2000 Jul; 164(1):53-9. PubMed ID: 10877915
[TBL] [Abstract][Full Text] [Related]
39. Fetal striatal transplants restore electrophysiological sensitivity to dopamine in the lesioned striatum of rats with experimental Huntington's disease.
Chen GJ; Jeng CH; Lin SZ; Tsai SH; Wang Y; Chiang YH
J Biomed Sci; 2002; 9(4):303-10. PubMed ID: 12145527
[TBL] [Abstract][Full Text] [Related]
40. Human neural stem cell transplants improve motor function in a rat model of Huntington's disease.
McBride JL; Behrstock SP; Chen EY; Jakel RJ; Siegel I; Svendsen CN; Kordower JH
J Comp Neurol; 2004 Jul; 475(2):211-9. PubMed ID: 15211462
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
